Proactiveinvestors USA & Canada Orgenesis https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Orgenesis RSS feed en Mon, 09 Dec 2019 02:09:39 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Orgenesis and Theracell to launch point-of-care cell and gene therapy centers in HYGEIA Group's hospitals https://www.proactiveinvestors.com/companies/news/908668/orgenesis-and-theracell-to-launch-point-of-care-cell-and-gene-therapy-centers-in-hygeia-group-s-hospitals-908668.html Fri, 06 Dec 2019 15:07:00 -0500 https://www.proactiveinvestors.com/companies/news/908668/orgenesis-and-theracell-to-launch-point-of-care-cell-and-gene-therapy-centers-in-hygeia-group-s-hospitals-908668.html Orgenesis sees fiscal 3Q revenue shoot up by 46% to a record $9.1M https://www.proactiveinvestors.com/companies/news/906645/orgenesis-sees-fiscal-3q-revenue-shoot-up-by-46-to-a-record-91m-906645.html Fri, 08 Nov 2019 13:09:00 -0500 https://www.proactiveinvestors.com/companies/news/906645/orgenesis-sees-fiscal-3q-revenue-shoot-up-by-46-to-a-record-91m-906645.html Orgenesis signs deal with Accellix, invites Academy Award winner on Scientific board https://www.proactiveinvestors.com/companies/news/906156/orgenesis-signs-deal-with-accellix-invites-academy-award-winner-on-scientific-board-906156.html Mon, 04 Nov 2019 12:45:00 -0500 https://www.proactiveinvestors.com/companies/news/906156/orgenesis-signs-deal-with-accellix-invites-academy-award-winner-on-scientific-board-906156.html Orgenesis names serial inventor, industry veteran Bala Manian to scientific advisory board https://www.proactiveinvestors.com/companies/news/906061/orgenesis-names-serial-inventor-industry-veteran-bala-manian-to-scientific-advisory-board-906061.html Thu, 31 Oct 2019 14:50:00 -0400 https://www.proactiveinvestors.com/companies/news/906061/orgenesis-names-serial-inventor-industry-veteran-bala-manian-to-scientific-advisory-board-906061.html Orgenesis inks co-development agreement with Accellix to improve quality control in its cellular therapy system https://www.proactiveinvestors.com/companies/news/904952/orgenesis-inks-co-development-agreement-with-accellix-to-improve-quality-control-in-its-cellular-therapy-system-904952.html Wed, 16 Oct 2019 13:10:00 -0400 https://www.proactiveinvestors.com/companies/news/904952/orgenesis-inks-co-development-agreement-with-accellix-to-improve-quality-control-in-its-cellular-therapy-system-904952.html Orgenesis realigns resources with internal business transfers to support continued growth https://www.proactiveinvestors.com/companies/news/900763/orgenesis-realigns-resources-with-internal-business-transfers-to-support-continued-growth-900763.html Wed, 14 Aug 2019 13:45:00 -0400 https://www.proactiveinvestors.com/companies/news/900763/orgenesis-realigns-resources-with-internal-business-transfers-to-support-continued-growth-900763.html Orgenesis Inc sees record fiscal 2Q revenue beat estimates https://www.proactiveinvestors.com/companies/news/900553/orgenesis-inc-sees-record-fiscal-2q-revenue-beat-estimates-900553.html Mon, 12 Aug 2019 14:45:00 -0400 https://www.proactiveinvestors.com/companies/news/900553/orgenesis-inc-sees-record-fiscal-2q-revenue-beat-estimates-900553.html Orgenesis gets Orphan Drug designation to treat severe diabetes https://www.proactiveinvestors.com/companies/news/313923/orgenesis-gets-orphan-drug-designation-to-treat-severe-diabetes-13923.html Fri, 28 Jun 2019 16:40:00 -0400 https://www.proactiveinvestors.com/companies/news/313923/orgenesis-gets-orphan-drug-designation-to-treat-severe-diabetes-13923.html Orgenesis wins Orphan Drug designation for AIP cells for treating severe diabetes https://www.proactiveinvestors.com/companies/news/222236/orgenesis-wins-orphan-drug-designation-for-aip-cells-for-treating-severe-diabetes-222236.html Mon, 17 Jun 2019 12:04:00 -0400 https://www.proactiveinvestors.com/companies/news/222236/orgenesis-wins-orphan-drug-designation-for-aip-cells-for-treating-severe-diabetes-222236.html Orgenesis explains the impacts of it's cell therapy development and manufacturing tech https://www.proactiveinvestors.com/companies/news/313628/orgenesis-explains-the-impacts-of-it-s-cell-therapy-development-and-manufacturing-tech-13628.html Wed, 05 Jun 2019 20:26:00 -0400 https://www.proactiveinvestors.com/companies/news/313628/orgenesis-explains-the-impacts-of-it-s-cell-therapy-development-and-manufacturing-tech-13628.html Orgenesis posts record fiscal 1Q profit, $7.3M in revenue as its contact manufacturing business booms https://www.proactiveinvestors.com/companies/news/219993/orgenesis-posts-record-fiscal-1q-profit-73m-in-revenue-as-its-contact-manufacturing-business-booms-219993.html Thu, 09 May 2019 14:35:00 -0400 https://www.proactiveinvestors.com/companies/news/219993/orgenesis-posts-record-fiscal-1q-profit-73m-in-revenue-as-its-contact-manufacturing-business-booms-219993.html Orgenesis CEO talks through most recent collaborations: 3D cell printing and exosome technologies https://www.proactiveinvestors.com/companies/news/313173/orgenesis-ceo-talks-through-most-recent-collaborations-3d-cell-printing-and-exosome-technologies-13173.html Wed, 01 May 2019 13:41:00 -0400 https://www.proactiveinvestors.com/companies/news/313173/orgenesis-ceo-talks-through-most-recent-collaborations-3d-cell-printing-and-exosome-technologies-13173.html Orgenesis to study liver cells as a suitable source for cell replacement therapy for insulin-dependent diabetics https://www.proactiveinvestors.com/companies/news/219401/orgenesis-to-study-liver-cells-as-a-suitable-source-for-cell-replacement-therapy-for-insulin-dependent-diabetics-219401.html Tue, 30 Apr 2019 16:45:00 -0400 https://www.proactiveinvestors.com/companies/news/219401/orgenesis-to-study-liver-cells-as-a-suitable-source-for-cell-replacement-therapy-for-insulin-dependent-diabetics-219401.html Orgenesis strikes deal with Columbia University to develop Cellular Vaccination product platform https://www.proactiveinvestors.com/companies/news/218894/orgenesis-strikes-deal-with-columbia-university-to-develop-cellular-vaccination-product-platform-218894.html Mon, 22 Apr 2019 14:39:00 -0400 https://www.proactiveinvestors.com/companies/news/218894/orgenesis-strikes-deal-with-columbia-university-to-develop-cellular-vaccination-product-platform-218894.html Orgenesis strikes collaboration, license deal for exosome technologies with ExcellaBio https://www.proactiveinvestors.com/companies/news/218434/orgenesis-strikes-collaboration-license-deal-for-exosome-technologies-with-excellabio-218434.html Thu, 11 Apr 2019 14:34:00 -0400 https://www.proactiveinvestors.com/companies/news/218434/orgenesis-strikes-collaboration-license-deal-for-exosome-technologies-with-excellabio-218434.html Orgenesis strikes deal to develop 3D printing for cellular structures and tissues https://www.proactiveinvestors.com/companies/news/217991/orgenesis-strikes-deal-to-develop-3d-printing-for-cellular-structures-and-tissues-217991.html Thu, 04 Apr 2019 16:24:00 -0400 https://www.proactiveinvestors.com/companies/news/217991/orgenesis-strikes-deal-to-develop-3d-printing-for-cellular-structures-and-tissues-217991.html Orgenesis showcases publication of diabetes study in Stem Cell Research and Therapy Journal https://www.proactiveinvestors.com/companies/news/217889/orgenesis-showcases-publication-of-diabetes-study-in-stem-cell-research-and-therapy-journal-217889.html Wed, 03 Apr 2019 14:58:00 -0400 https://www.proactiveinvestors.com/companies/news/217889/orgenesis-showcases-publication-of-diabetes-study-in-stem-cell-research-and-therapy-journal-217889.html Orgenesis gains after announcing venture with TheraCell for cell and gene therapy development https://www.proactiveinvestors.com/companies/news/217442/orgenesis-gains-after-announcing-venture-with-theracell-for-cell-and-gene-therapy-development-217442.html Thu, 28 Mar 2019 10:17:00 -0400 https://www.proactiveinvestors.com/companies/news/217442/orgenesis-gains-after-announcing-venture-with-theracell-for-cell-and-gene-therapy-development-217442.html Orgenesis subsidiary MaSTherCell Global to build new facility in Belgium for cell and gene therapy manufacturing https://www.proactiveinvestors.com/companies/news/217146/orgenesis-subsidiary-masthercell-global-to-build-new-facility-in-belgium-for-cell-and-gene-therapy-manufacturing-217146.html Mon, 25 Mar 2019 14:51:00 -0400 https://www.proactiveinvestors.com/companies/news/217146/orgenesis-subsidiary-masthercell-global-to-build-new-facility-in-belgium-for-cell-and-gene-therapy-manufacturing-217146.html Orgenesis leads the charge at an exciting time for cell therapy https://www.proactiveinvestors.com/companies/news/216323/orgenesis-leads-the-charge-at-an-exciting-time-for-cell-therapy-216323.html Tue, 12 Mar 2019 07:15:00 -0400 https://www.proactiveinvestors.com/companies/news/216323/orgenesis-leads-the-charge-at-an-exciting-time-for-cell-therapy-216323.html Orgenesis stock climbs after it posts 139% expansion in gross profit for fiscal 2018 on revenue surge https://www.proactiveinvestors.com/companies/news/214660/orgenesis-stock-climbs-after-it-posts-139-expansion-in-gross-profit-for-fiscal-2018-on-revenue-surge-214660.html Thu, 14 Feb 2019 15:28:00 -0500 https://www.proactiveinvestors.com/companies/news/214660/orgenesis-stock-climbs-after-it-posts-139-expansion-in-gross-profit-for-fiscal-2018-on-revenue-surge-214660.html Orgenesis unveils new offices, labs at Accessia Pharma in Belgium to boost its point-of-care cellular therapy platform https://www.proactiveinvestors.com/companies/news/214020/orgenesis-unveils-new-offices-labs-at-accessia-pharma-in-belgium-to-boost-its-point-of-care-cellular-therapy-platform-214020.html Tue, 05 Feb 2019 15:40:00 -0500 https://www.proactiveinvestors.com/companies/news/214020/orgenesis-unveils-new-offices-labs-at-accessia-pharma-in-belgium-to-boost-its-point-of-care-cellular-therapy-platform-214020.html Orgenesis subsidiary MaSTherCell Global expanding into the US https://www.proactiveinvestors.com/companies/news/312058/orgenesis-subsidiary-masthercell-global-expanding-into-the-us-12058.html Thu, 31 Jan 2019 20:15:00 -0500 https://www.proactiveinvestors.com/companies/news/312058/orgenesis-subsidiary-masthercell-global-expanding-into-the-us-12058.html Orgenesis kicks off US expansion of MaSTherCell Global subsidiary with Houston facility https://www.proactiveinvestors.com/companies/news/213368/orgenesis-kicks-off-us-expansion-of-masthercell-global-subsidiary-with-houston-facility-213368.html Fri, 25 Jan 2019 18:59:00 -0500 https://www.proactiveinvestors.com/companies/news/213368/orgenesis-kicks-off-us-expansion-of-masthercell-global-subsidiary-with-houston-facility-213368.html HekaBio CEO says Orgenesis taken 'great steps' to solve biotech manufacturing cost problem https://www.proactiveinvestors.com/companies/news/311814/hekabio-ceo-says-orgenesis-taken--great-steps--to-solve-biotech-manufacturing-cost-problem-11814.html Fri, 11 Jan 2019 18:51:00 -0500 https://www.proactiveinvestors.com/companies/news/311814/hekabio-ceo-says-orgenesis-taken--great-steps--to-solve-biotech-manufacturing-cost-problem-11814.html Orgenesis CEO says investors realizing building out infrastructure in biotechs is important https://www.proactiveinvestors.com/companies/news/311789/orgenesis-ceo-says-investors-realizing-building-out-infrastructure-in-biotechs-is-important-11789.html Thu, 10 Jan 2019 20:48:00 -0500 https://www.proactiveinvestors.com/companies/news/311789/orgenesis-ceo-says-investors-realizing-building-out-infrastructure-in-biotechs-is-important-11789.html Biotech CEOs gather in San Francisco to mull 2019 outlook https://www.proactiveinvestors.com/companies/news/211991/biotech-ceos-gather-in-san-francisco-to-mull-2019-outlook-211991.html Fri, 04 Jan 2019 18:40:00 -0500 https://www.proactiveinvestors.com/companies/news/211991/biotech-ceos-gather-in-san-francisco-to-mull-2019-outlook-211991.html Orgenesis to present at Biotech Showcase in San Francisco next week https://www.proactiveinvestors.com/companies/news/311698/orgenesis-to-present-at-biotech-showcase-in-san-francisco-next-week-11698.html Thu, 03 Jan 2019 17:02:00 -0500 https://www.proactiveinvestors.com/companies/news/311698/orgenesis-to-present-at-biotech-showcase-in-san-francisco-next-week-11698.html Orgenesis collaborates with MangoGen Pharma for advanced gene delivery platform https://www.proactiveinvestors.com/companies/news/211435/orgenesis-collaborates-with-mangogen-pharma-for-advanced-gene-delivery-platform-211435.html Tue, 18 Dec 2018 20:07:00 -0500 https://www.proactiveinvestors.com/companies/news/211435/orgenesis-collaborates-with-mangogen-pharma-for-advanced-gene-delivery-platform-211435.html Orgenesis CEO Vered Caplan says it's a 'very exciting time' for cell therapy in Fox interview https://www.proactiveinvestors.com/companies/news/211174/orgenesis-ceo-vered-caplan-says-it-s-a--very-exciting-time--for-cell-therapy-in-fox-interview-211174.html Thu, 13 Dec 2018 15:45:00 -0500 https://www.proactiveinvestors.com/companies/news/211174/orgenesis-ceo-vered-caplan-says-it-s-a--very-exciting-time--for-cell-therapy-in-fox-interview-211174.html Orgenesis seals pact with Ben-Gurion University to develop dissolvable carriers for cell culturing https://www.proactiveinvestors.com/companies/news/211072/orgenesis-seals-pact-with-ben-gurion-university-to-develop-dissolvable-carriers-for-cell-culturing-211072.html Wed, 12 Dec 2018 14:50:00 -0500 https://www.proactiveinvestors.com/companies/news/211072/orgenesis-seals-pact-with-ben-gurion-university-to-develop-dissolvable-carriers-for-cell-culturing-211072.html Orgenesis subsidiary Masthercell Global unveils new production wing at Belgian plant https://www.proactiveinvestors.com/companies/news/210320/orgenesis-subsidiary-masthercell-global-unveils-new-production-wing-at-belgian-plant-210320.html Fri, 30 Nov 2018 14:22:00 -0500 https://www.proactiveinvestors.com/companies/news/210320/orgenesis-subsidiary-masthercell-global-unveils-new-production-wing-at-belgian-plant-210320.html Orgenesis teams up with New York Blood Center for tissue collection, biobanking US cell therapy development program https://www.proactiveinvestors.com/companies/news/209693/orgenesis-teams-up-with-new-york-blood-center-for-tissue-collection-biobanking-us-cell-therapy-development-program-209693.html Wed, 21 Nov 2018 15:11:00 -0500 https://www.proactiveinvestors.com/companies/news/209693/orgenesis-teams-up-with-new-york-blood-center-for-tissue-collection-biobanking-us-cell-therapy-development-program-209693.html Orgenesis teams up with HemoGenyx in second collaboration to push cancer cell replacement product to clinical trials https://www.proactiveinvestors.com/companies/news/311105/orgenesis-teams-up-with-hemogenyx-in-second-collaboration-to-push-cancer-cell-replacement-product-to-clinical-trials-11105.html Mon, 05 Nov 2018 16:09:00 -0500 https://www.proactiveinvestors.com/companies/news/311105/orgenesis-teams-up-with-hemogenyx-in-second-collaboration-to-push-cancer-cell-replacement-product-to-clinical-trials-11105.html Orgenesis teams up with HemoGenyx to develop its AHC platform in ‘exciting’ deal https://www.proactiveinvestors.com/companies/news/311104/orgenesis-teams-up-with-hemogenyx-to-develop-its-ahc-platform-in-exciting-deal-11104.html Mon, 05 Nov 2018 16:02:00 -0500 https://www.proactiveinvestors.com/companies/news/311104/orgenesis-teams-up-with-hemogenyx-to-develop-its-ahc-platform-in-exciting-deal-11104.html Orgenesis CEO says companies looking for ways to get costs of medicine down https://www.proactiveinvestors.com/companies/news/208450/orgenesis-ceo-says-companies-looking-for-ways-to-get-costs-of-medicine-down-208450.html Fri, 02 Nov 2018 20:17:00 -0400 https://www.proactiveinvestors.com/companies/news/208450/orgenesis-ceo-says-companies-looking-for-ways-to-get-costs-of-medicine-down-208450.html Orgenesis' cell therapy development business pushes into the US https://www.proactiveinvestors.com/companies/news/311058/orgenesis-cell-therapy-development-business-pushes-into-the-us-11058.html Wed, 31 Oct 2018 12:51:00 -0400 https://www.proactiveinvestors.com/companies/news/311058/orgenesis-cell-therapy-development-business-pushes-into-the-us-11058.html Orgenesis, Geneius to present at 'The Cellular Living Drug Revolution Summit' in New York https://www.proactiveinvestors.com/companies/news/310974/orgenesis-geneius-to-present-at-the-cellular-living-drug-revolution-summit-in-new-york-10974.html Wed, 24 Oct 2018 20:42:00 -0400 https://www.proactiveinvestors.com/companies/news/310974/orgenesis-geneius-to-present-at-the-cellular-living-drug-revolution-summit-in-new-york-10974.html Orgenesis revenue nearly doubled in fiscal second quarter on CAR T-cell therapies https://www.proactiveinvestors.com/companies/news/200984/orgenesis-revenue-nearly-doubled-in-fiscal-second-quarter-on-car-t-cell-therapies-200984.html Tue, 17 Jul 2018 19:24:00 -0400 https://www.proactiveinvestors.com/companies/news/200984/orgenesis-revenue-nearly-doubled-in-fiscal-second-quarter-on-car-t-cell-therapies-200984.html Orgenesis to conduct clinical trials for Type 1 diabetes treatment in Russia https://www.proactiveinvestors.com/companies/news/119663/orgenesis-to-conduct-clinical-trials-for-type-1-diabetes-treatment-in-russia-119663.html Tue, 24 Nov 2015 16:41:00 -0500 https://www.proactiveinvestors.com/companies/news/119663/orgenesis-to-conduct-clinical-trials-for-type-1-diabetes-treatment-in-russia-119663.html Orgenesis forms strategic collaboration with Lyfebulb https://www.proactiveinvestors.com/companies/news/119577/orgenesis-forms-strategic-collaboration-with-lyfebulb-119577.html Mon, 23 Nov 2015 13:16:00 -0500 https://www.proactiveinvestors.com/companies/news/119577/orgenesis-forms-strategic-collaboration-with-lyfebulb-119577.html